Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

The phosphoinositide 3-kinase (PI3K) pathway is activated in most advanced prostate cancers, yet so far treatments with PI3K inhibitors have been at best tumorostatic in preclinical cancer models and do not show significant antitumor efficacy in clinical trials. Results from tissue culture experimen...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Baiz, Daniele, Hassan, Sazzad, Choi, Young A, Flores, Anabel, Karpova, Yelena, Yancey, Dana, Pullikuth, Ashok, Sui, Guangchao, Sadelain, Michel, Debinski, Waldemar, Kulik, George
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press Inc. 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3819633/
https://ncbi.nlm.nih.gov/pubmed/24204196
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky